Cargando…

Attack phenotypes and disease course in pediatric MOGAD

Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) is an autoimmune demyelinating condition that affects children differently than adults. We performed a literature review to assess the presentation and clinical course of pediatric MOGAD. The most common initial phenotype is acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Jonathan D., Beukelman, Timothy, Hemingway, Cheryl, Hokkanen, Suvi R. K., Tennigkeit, Frank, Chitnis, Tanuja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187731/ https://www.ncbi.nlm.nih.gov/pubmed/37000895 http://dx.doi.org/10.1002/acn3.51759

Ejemplares similares

Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
por: Nosadini, Margherita, et al.
Publicado: (2022)

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course
por: Rechtman, Ariel, et al.
Publicado: (2022)

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
por: Sen, Sedat, et al.
Publicado: (2022)

Clinical and neuroimaging findings in MOGAD–MRI and OCT
por: Bartels, Frederik, et al.
Publicado: (2021)

Editorial: MOGAD, current knowledge and future trends
por: Siritho, Sasitorn, et al.
Publicado: (2023)

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina
por: Contentti, Edgar Carnero, et al.
Publicado: (2021)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis()
por: Santoro, Jonathan D., et al.
Publicado: (2019)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023)

Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
por: Santoro, Jonathan D., et al.
Publicado: (2023)

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
por: Yandamuri, Soumya S., et al.
Publicado: (2023)

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode
por: Pakeerathan, T., et al.
Publicado: (2022)

Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2
por: Graf, Jonas, et al.
Publicado: (2020)

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1
por: Graf, Jonas, et al.
Publicado: (2020)

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Demystifying MOGAD and Double Seronegative NMOSD Further With IL-6 Blockade
por: Yong, Kok Pin, et al.
Publicado: (2021)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
por: Yao, Yajun, et al.
Publicado: (2022)

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
por: Fan, Xiao, et al.
Publicado: (2022)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
por: Du, Yangsa, et al.
Publicado: (2022)

The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD
por: Berhanu, David, et al.
Publicado: (2023)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
por: Lotan, Itay, et al.
Publicado: (2023)

A Case of MOGAD Complicated With Cerebral Vasculitis: Case Report and Literature Review
por: Cao, Yimin, et al.
Publicado: (2023)

Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
por: Kim, Sohyeon, et al.
Publicado: (2023)

Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review
por: Molazadeh, Negar, et al.
Publicado: (2022)

MOG antibody associated disease (MOGAD) presenting with extensive brain stem encephalitis: A case report
por: Olbert, Elisabeth, et al.
Publicado: (2022)

High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge
por: Azar, Chadi, et al.
Publicado: (2023)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Exploration of machine learning techniques in predicting multiple sclerosis disease course
por: Zhao, Yijun, et al.
Publicado: (2017)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
por: Malli, Chaithra, et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
por: Gadama, Yohane, et al.
Publicado: (2023)

Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies
por: Asseyer, Susanna, et al.
Publicado: (2020)

Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
por: Li, Yunjie, et al.
Publicado: (2022)

Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study
por: Zhao, Yijun, et al.
Publicado: (2020)

The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis
por: Chitnis, Tanuja
Publicado: (2007)

Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
por: Dinoto, Alessandro, et al.
Publicado: (2022)

General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): A case report
por: Hong, Seung-Wan, et al.
Publicado: (2022)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
por: Hiya, Satomi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_60hi5rkh7q7l6suqmmkk38g4pn